epitope corresponding to amino acids 2161-2460 mapping near the C-terminus of PARC of human origin
Modification Notes
The p53 tumor suppressor gene is altered in over 50% of human cancers. The p53 binding proteins 53BP1 and 53BP2 (Bbp) are tumor suppressors that bind to the site-specific central DNA-binding domain of wild type p53 in a conformation-dependent manner. Severe DNA damage can cause phosphorylation of p53 at position serine-46. This event triggers expression of p53AIP1 (apoptosis inducing protein), which contributes to subsequent events leading to programmed cell death. The protein PARC (p53 associated Parkin-like cytoplasmic protein) acts as a cytoplasmic anchor for p53 in unstressed cells, thereby regulating the localization and subsequent function of p53. The C-terminus of the PARC protein contains a RING-IBR-RING domain, which suggests it retains ubiquitin ligase activity, but PARC fails to promote degradation of p53. The gene encoding human PARC maps to chromosome 6p21.1.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of p53-associated Parkin-like cytoplasmic protein of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including equine, canine and porcine:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 2161-2460 mapping near the C-terminus of PARC of human origin
Tissue Specificity
epitope corresponding to amino acids 2161-2460 mapping near the C-terminus of PARC of human origin
recommended for detection of p53-associated Parkin-like cytoplasmic protein of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including equine, canine and porcine:
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.